Search results
Left Atrial Appendage Closure Devices for Stroke Prevention in Patients with Non-Valvular AF
Author(s):
Daniel A McBride
,
Timothy M Markman
,
Jackson J Liang
,
et al
Added:
3 years ago
Article
Author(s):
Felicity Champney
Added:
5 years ago
Supporting the EP lab team - Tools and techniques for improved cyroablation procedural experience.
Felicity Champney RN
Filmed by Radcliffe Cardiology on site at EHRA 2018.
View more
Author(s):
Davide Cao
Added:
2 years ago
Dr Davide Cao (Icahn School of Medicine at Mount Sinai, US) discusses the key results and impact on clinical practice of the pre-specified analysis of the TWILIGHT trial presented at ESC Congress 2021.
TWILIGHT-HBR evaluated the effects of ticagrelor monotherapy versus ticagrelor (Brilinta) plus aspirin on bleeding and ischemic outcomes in a contemporary ARC-defined HBR population undergoing…
View more
Author(s):
Paul A Friedman
,
Stephen C Hammill
Added:
3 years ago
Atrial fibrillation (AF) is a rhythm disturbance of the atria that results in irregular, chaotic, ventricular waveforms, varying from bradyarrhythmia to tachyarrhythmia. Essentially, all forms of AF therapy can be divided into two categories - restoration and maintenance of normal sinus rhythm, or control of the ventricular rate while permitting on-going fibrillation of the atria. Although…
View more
Author(s):
Gregory Marcus
Added:
2 years ago
Dr Gregory Marcus (University of California, San Francisco, CA, US) shares the results from the HOLIDAY Monitors Trial. This study assessed how ethanol may trigger episodes of atrial fibrillation (AF).
Questions
What is the HOLIDAY Monitors Trial and what does it aim to address?
What was the study design, patient population and endpoints?
What are the main findings to date?
What conclusions can…
View more
Author(s):
A Michael Lincoff
,
Harriette Van Spall
Added:
4 months ago
AHA 2023 — Investigator, Dr A Michael Lincoff (Cleveland Clinic, US) sat down with Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the SELECT trial (NCT03574597).In this randomized, double-blind, parallel-group, placebo-controlled trial sponsored by Novo Nordisk, semaglutide was compared with a placebo in patients who have overweight or obesity and a history of…
View more
Added:
5 years ago
Dr Nicholas W Shammas (Midwest Cardiovascular Research Foundation, Davenport, IA, US) discusses the B-laser IDE study.
Filmed on site at CRT 2019 by Radcliffe Cardiology.
Questions:
1. What is the rationale for this study?
2. Could you describe the study design and technology used?
3. What were your findings?
4. What implications should this data have for clinical practice and future…
View more
Author(s):
Paul Wang
Added:
1 year ago
AHA 22: Dr Paul Wang (Cardiac Arrhythmia Service at Palo Alto, Stanford, CA, US) joins us remotely to discuss the findings of the ENHANCE-AF trial, originally presented at the American Heart Association's 2022 Scientific Sessions.
ENHANCE AF aimed to evaluate whether a shared-decision-making pathway tool would reduce the risk of stroke as a result of atrial fibrillation when compared to standard…
View more
Author(s):
Maurizio Gasparini
Added:
6 years ago
Maurizio Gasparini from Humanitas Research Hospital, Milan, Italy discusses ADVANCE III: Avoid delivering therapies for non-sustained arrhythmias in ICD patients III.
Filmed by Radcliffe Cardiology on-site at HRS 2017.
View more
Author(s):
Jack McCready
Added:
5 years ago
Supporting the EP lab team - Tools and techniques for improved cyroablation procedural experience.
Dr Jack McCready & Felicity Champney RN
View more